Leaderboards/Multiple and Secondary Primary Cancers

Multiple and Secondary Primary Cancers

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Jianhui Zhao
Hainan General Hospital
2
Pariyada Tanjak
Siriraj Hospital
3
Janice Kim
University of California, Los Angeles
4
К. В. Сафронова
Ministry of Health of the Russian Federation
5
Qianru Li
Hangzhou Medical College
6
Atalel Fentahun Awedew
Debre Tabor University
7
Wenwen Cai
Shanxi Academy of Medical Sciences
8
Marion Jaffrelot
Centre Hospitalier Universitaire de Toulouse
9
Xinxin Yan
Wuhan Institute of Technology
10
Kai‐Keen Shiu
University College London Hospitals NHS Foundation Trust

Rising Stars Papers

1
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
Chinese Medical Journal|2024
87 cit.
2
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
Frontiers of Medicine|2024
80 cit.
3
The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000–2021: a systematic analysis for the Global Burden of Disease Study 2021
EClinicalMedicine|2024
76 cit.
4
Spatial Structure of Electron Interactions in High‐entropy Oxide Nanoparticles for Active Electrocatalysis of Carbon Dioxide Reduction
Advanced Materials|2024
58 cit.
5
NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.
Journal of Clinical Oncology|2024
33 cit.
6
Sustainable bioleaching of heavy metals from coal tailings using Bacillus inaquosorum B.4: Mechanistic insights and environmental implications
Journal of environmental chemical engineering|2024
22 cit.
7
Enhancing Initial Surface Adsorption for Doped Lead‐Free Copper(I) Halide Microcrystals Through a Moderate Lewis Base Ligand
Advanced Functional Materials|2024
20 cit.
8
Tumor-immune hybrid cells evade the immune response and potentiate colorectal cancer metastasis through CTLA4
Clinical and Experimental Medicine|2024
16 cit.
9
Intelligent MEMS Thermal Mass Flowmeter Based on Modified Sage-Husa Adaptive Robust-Strong Tracking Kalman Filtering
IEEE Sensors Journal|2024
13 cit.
10
Spatial Transcriptomic Profiling of Tetraspanins in Stage 4 Colon Cancer from Primary Tumor and Liver Metastasis
Life|2024
8 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Angela D. Motter
National Comprehensive Cancer Network
2
Monica Bryant
Skin Cancer Foundation
3
Jiao Yang
Shanghai Sixth People's Hospital
4
Xue Li
Department of Health
5
Kevin A. Look
University of Wisconsin–Madison
6
Darren R. Brenner
University of Calgary
7
Suresh Manapuram
Saint Francis Hospital & Medical Center
8
Scot A. Fisher
Thomas Jefferson University
9
Wanqing Chen
Chinese Academy of Medical Sciences & Peking Union Medical College
10
Irmina Maria Michałek
National Institute of Oncology

Emerging Leaders Papers

1
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
655 cit.
2
Projected estimates of cancer in Canada in 2022
Canadian Medical Association Journal|2022
306 cit.
3
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019
BMJ Oncology|2023
279 cit.
4
Comparative analysis of cancer statistics in China and the United States in 2024
Chinese Medical Journal|2024
141 cit.
5
Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease
EBioMedicine|2023
134 cit.
6
Projected estimates of cancer in Canada in 2024
Canadian Medical Association Journal|2024
128 cit.
7
Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
Chinese Medical Journal|2024
87 cit.
8
Disparities in 36 cancers across 185 countries: secondary analysis of global cancer statistics
Frontiers of Medicine|2024
80 cit.
9
Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study
Alimentary Pharmacology & Therapeutics|2023
61 cit.
10
Sedentary lifestyle, physical activity, and gastrointestinal diseases: evidence from mendelian randomization analysis
EBioMedicine|2024
60 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Freddie Bray
Centre international de recherche sur le cancer
2
Ahmedin Jemal
American Cancer Society
3
Donald Maxwell Parkin
University of Oxford
4
Elizabeth Ward
American Cancer Society
5
Carlo La Vecchia
University of Milan
6
Jill S. Barnholtz‐Sloan
Emory University
7
Kari Hemminki
German Cancer Research Center
8
Brent K. Hollenbeck
University of Michigan
9
Riccardo Capocaccia
Departamento de Epidemiología
10
David Cella
Northwestern University

Current Senior Leaders Papers

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
CA A Cancer Journal for Clinicians|2021
112.5k cit.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2018
87.7k cit.
3
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
4
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
International Journal of Cancer|2014
29k cit.
5
Global cancer statistics, 2012
CA A Cancer Journal for Clinicians|2015
27.4k cit.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
23.1k cit.
7
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
International Journal of Cancer|2010
21.4k cit.
8
Cancer statistics, 2020
CA A Cancer Journal for Clinicians|2020
21.4k cit.
9
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
21k cit.
10
Global Cancer Statistics, 2002
CA A Cancer Journal for Clinicians|2005
18.4k cit.

Reagents for Multiple and Secondary Primary Cancers

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

VASP (9A2) Rabbit Monoclonal Antibody

#3132$149,348
View Evidence →
Cell Signaling TechnologyEvidence 66

VGLUT2 (D7D2H) Rabbit Monoclonal Antibody

#71555$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

Phospho-ATF-2 (Thr71)/ATF-7 (Thr53) (A8J7P) Rabbit Monoclonal Antibody

#15411$176,415
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

WSTF Antibody

Cited in 5 papers
#2152$317
View Evidence →
Cell Signaling TechnologyEvidence 70

cGAS (E5V3W) Rabbit Monoclonal Antibody (BSA and Azide Free)

#86793$865
View Evidence →
Cell Signaling TechnologyEvidence 65

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#94805$465
View Evidence →